Viewing Study NCT02139358

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:21 AM

Ignite Modification Date: 2025-12-25 @ 10:25 PM

Study NCT ID: NCT02139358

Status: COMPLETED

Last Update Posted: 2021-02-04

First Post: 2014-05-13

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module